MACROGEN Renews CI After 19 Years, Making A Great Leap Forward To Be A Global Leader Of Personalized Genomic Medicine
SEOUL, South Korea--(BUSINESS WIRE)--The personalized medicine and biotechnology company, Macrogen (headed by Hyonyong Chong; www.macrogen.com) (KOSDAQ:038290), has announced a new Corporate Identity (CI) for a great leap forward to become a global leader of personalized genomic medicine.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.